ArticleAmerican journal of preventive cardiology2025

Evidence-based SGLT2 inhibitor and GLP-1 receptor agonist use by race in the VA healthcare system.

Demetria M Bolden et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.